Lifeward's ReWalk® Personal Exoskeleton Demonstrates Sustained Long-Term Home Use and Patient Satisfaction in Latest Independent Peer-Reviewed StudyGlobeNewsWire · Oct 14, 2026
Peer-Reviewed Study of Lifeward's ReWalk® Exoskeleton Reports Significant Improvements in Daily Activity Performance, Satisfaction, and PainGlobeNewsWire · Sep 15, 2026
Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth StrategyGlobeNewsWire · Sep 8, 2026
Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial OfficerGlobeNewsWire · Aug 31, 2026
Lifeward (LFWD) Reports Q2 Loss, Misses Revenue EstimatesZacks Investment Research · Aug 14, 2026
Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives GrowthGlobeNewsWire · Aug 14, 2026Lifeward Ltd. is a healthcare technology company specializing in the creation, development, and commercialization of wearable robotic exoskeletons. These sophisticated devices are engineered to restore lower limb mobility for individuals living with spinal cord injuries (SCI), granting them the ability to stand, walk, pivot, and navigate staircases by providing assistive hip and knee motion. Key offerings from the company include the ReWalk Exo-Suit and the ReWalk Personal 6.0.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 14, 2026 | -$1.39 | -$1.46 | Miss |
| May 15, 2026 | -$0.34 | -$6.70 | Miss |
| Mar 18, 2026 | -$0.84 | -$3.60 | Miss |
| Nov 14, 2025 | -$0.14 | -$2.28 | Miss |
| Aug 14, 2025 | -$3.00 | -$6.96 | Miss |
| May 15, 2025 | -$3.96 | -$5.52 | Miss |